M. Essink

447 total citations
11 papers, 320 citations indexed

About

M. Essink is a scholar working on Oncology, Infectious Diseases and Epidemiology. According to data from OpenAlex, M. Essink has authored 11 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Infectious Diseases and 4 papers in Epidemiology. Recurrent topics in M. Essink's work include Neutropenia and Cancer Infections (5 papers), Antifungal resistance and susceptibility (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). M. Essink is often cited by papers focused on Neutropenia and Cancer Infections (5 papers), Antifungal resistance and susceptibility (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). M. Essink collaborates with scholars based in Germany, United Kingdom and Malaysia. M. Essink's co-authors include Wolfgang Hiddemann, B. Wörmann, J. van de Loo, N. Roos, Gerhard Behre, I. Schedel, Thomas Büchner, Th. Büchner, W. Fegeler and A. Thiel and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Cancer.

In The Last Decade

M. Essink

11 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Essink Germany 8 89 87 82 81 65 11 320
J. van de Loo Germany 8 70 0.8× 51 0.6× 34 0.4× 40 0.5× 26 0.4× 33 332
Sadaya Matano Japan 12 120 1.3× 69 0.8× 51 0.6× 20 0.2× 40 0.6× 43 388
L. S. Zubarovskaya Russia 9 62 0.7× 64 0.7× 78 1.0× 50 0.6× 53 0.8× 140 297
A Merlat France 7 49 0.6× 79 0.9× 183 2.2× 52 0.6× 89 1.4× 8 465
A. De Laurenzi Italy 9 92 1.0× 144 1.7× 50 0.6× 26 0.3× 32 0.5× 22 314
Fumihiko Monma Japan 13 89 1.0× 93 1.1× 70 0.9× 94 1.2× 112 1.7× 35 496
Timi Martelius Finland 13 76 0.9× 200 2.3× 97 1.2× 25 0.3× 69 1.1× 37 577
Montserrat Rovira Spain 9 110 1.2× 76 0.9× 42 0.5× 32 0.4× 34 0.5× 24 352
Chiara Ghiggi Italy 8 65 0.7× 75 0.9× 134 1.6× 45 0.6× 59 0.9× 24 318
Effie Liakopoulou United Kingdom 10 176 2.0× 110 1.3× 133 1.6× 29 0.4× 102 1.6× 21 518

Countries citing papers authored by M. Essink

Since Specialization
Citations

This map shows the geographic impact of M. Essink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Essink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Essink more than expected).

Fields of papers citing papers by M. Essink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Essink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Essink. The network helps show where M. Essink may publish in the future.

Co-authorship network of co-authors of M. Essink

This figure shows the co-authorship network connecting the top 25 collaborators of M. Essink. A scholar is included among the top collaborators of M. Essink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Essink. M. Essink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Patel, Naina, Shekhar Krishnan, Marc N. Offman, et al.. (2009). A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug l-asparaginase. Journal of Clinical Investigation. 119(7). 1964–73. 81 indexed citations
3.
Silling, Gerda, W. Fegeler, N. Roos, M. Essink, & Thomas Büchner. (1999). Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine. Mycoses. 42(S2). 101–104. 22 indexed citations
5.
Hiddemann, Wolfgang, B. Wörmann, A. Thiel, et al.. (1991). Treatment of advanced chronic lymphocytic leukemia by fludarabine. Annals of Hematology. 63(1). 1–4. 65 indexed citations
7.
Eiff, M. von, M. Essink, N. Roos, et al.. (1990). Hepatosplenic candidiasis, a late manifestation of Candida septicaemia in neutropenic patients with haematologic malignancies. Annals of Hematology. 60(4). 242–248. 41 indexed citations
8.
Eiff, M. von, M. Essink, N. Roos, et al.. (1990). Hepatosplenic Candidiasis in Acute Leukemias. Hämatologie und Bluttransfusion. 33. 555–557. 2 indexed citations
9.
Siegert, W., Wolfgang Hiddemann, Renate Koppensteiner, et al.. (1989). Accidental overdose of mitoxantrone in three patients. Medical Oncology and Tumor Pharmacotherapy. 6(4). 275–278. 6 indexed citations
10.
Hiddemann, Wolfgang, Thomas Büchner, M. Essink, et al.. (1988). High-Dose Cytosine Arabinoside and Mitoxantrone: Preliminary Results of a Pilot Study with Sequential Application (S-HAM) Indicating a High Antileukemic Activity in Refractory Acute Leukemias. Oncology Research and Treatment. 11(1). 10–12. 9 indexed citations
11.
Essink, M., et al.. (1988). [Clinical course and risk factors in patients with generalized mycoses].. PubMed. 118(16). 584–91. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026